Vestal Point Capital’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Vestal Point Capital's BIIB Position: Q4 2025 in Review
Vestal Point Capital sold out of Biogen (BIIB) in Q4 2025, closing a stake of 275,000 shares — an estimated $38.5M sold.
Vestal Point Capital first reported a position in BIIB in Q4 2023 and held it in 2 quarters. The position peaked at $38.5M in Q3 2025. 997 funds tracked by Wall St. Rank hold BIIB as of Q4 2025.
- Vestal Point Capital reported no remaining Biogen position as of Q4 2025 after selling out during the quarter.
- Vestal Point Capital sold 275,000 Biogen shares in Q4 2025, an estimated $38.5M.
- Vestal Point Capital first reported a position in Biogen in Q4 2023 and held it in 2 quarters.
- Vestal Point Capital's Biogen position peaked at $38.5M in Q3 2025.
- 997 funds tracked by Wall St. Rank held Biogen as of Q4 2025.
Based on Vestal Point Capital's 13F filing for Q4 2025, filed 17 Feb 2026.